NITI Aayog proposes ₹50,000 crore fund to make India global biotech power
NITI Aayog has proposed a ₹50,000 crore BioEconomy Growth Fund to establish India as a global biotechnology leader by 2035. The roadmap includes production-linked incentives and six national missions to bridge the gap between research and commercial manufacturing.
Why it matters
The proposal signals a strategic government push to scale India's biotechnology sector, aiming for significant economic growth and job creation in high-tech fields.
A NITI Aayog roadmap has proposed creating a ₹50,000 crore BioEconomy Growth Fund, a dedicated production-linked incentive (PLI) scheme for biomanufacturing and six national biotechnology missions as part of an ambitious strategy to transform India into one of the world’s top three biotechnology powers by 2035.
The report, Roadmap for Building India as a Leading BioEconomy Powerhouse by 2035 , was made public on Thursday (July 16, 2026). It says India should move beyond the broad framework laid out under the Biotechnology for Economy, Environment and Employment (BioE3) policy and adopt a mission-mode execution strategy backed by new financing, regulatory reforms and cross-ministerial governance. It targets expanding India’s bioeconomy from $195.3 billion in 2025 to $691 billion by 2035 and $2.6 trillion by 2047, while generating more than 30 million high-value jobs.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in